ArticleTherapeutic advances in medical oncology2020

Efficacy and safety of apatinib as third- or further-line therapy for patients with advanced NSCLC: a retrospective study.

Jianmiao Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.